D.E. Shaw & Co’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.3M | Buy |
4,389,477
+2,800,365
| +176% | +$25.1M | 0.03% | 452 |
|
|
2025
Q1 | $11.9M | Buy |
1,589,112
+1,273,849
| +404% | +$9.55M | 0.01% | 909 |
|
|
2024
Q4 | $2.37M | Buy |
315,263
+86,173
| +38% | +$648K | ﹤0.01% | 1713 |
|
|
2024
Q3 | $1.74M | Sell |
229,090
-121,710
| -35% | -$925K | ﹤0.01% | 1864 |
|
|
2024
Q2 | $2.17M | Buy |
350,800
+316,924
| +936% | +$1.96M | ﹤0.01% | 1757 |
|
|
2024
Q1 | $172K | Buy |
33,876
+3,245
| +11% | +$16.5K | ﹤0.01% | 2777 |
|
|
2023
Q4 | $183K | Buy |
+30,631
| New | +$183K | ﹤0.01% | 2704 |
|
|
2023
Q3 | – | Sell |
-10,403
| Closed | -$73.2K | – | 3057 |
|
|
2023
Q2 | $73.2K | Sell |
10,403
-123,320
| -92% | -$868K | ﹤0.01% | 2719 |
|
|
2023
Q1 | $1.12M | Sell |
133,723
-399,530
| -75% | -$3.33M | ﹤0.01% | 2139 |
|
|
2022
Q4 | $6.12M | Buy |
533,253
+37,714
| +8% | +$433K | 0.01% | 1314 |
|
|
2022
Q3 | $6.24M | Buy |
+495,539
| New | +$6.24M | 0.01% | 1260 |
|
|
2022
Q2 | – | Sell |
-519,050
| Closed | -$8.44M | – | 4150 |
|
|
2022
Q1 | $8.44M | Sell |
519,050
-613,215
| -54% | -$9.97M | 0.01% | 1237 |
|
|
2021
Q4 | $15.7M | Buy |
1,132,265
+159,731
| +16% | +$2.21M | 0.01% | 832 |
|
|
2021
Q3 | $14M | Buy |
972,534
+100,008
| +11% | +$1.44M | 0.01% | 849 |
|
|
2021
Q2 | $13.8M | Buy |
872,526
+811,723
| +1,335% | +$12.8M | 0.01% | 886 |
|
|
2021
Q1 | $618K | Buy |
60,803
+17,163
| +39% | +$174K | ﹤0.01% | 2413 |
|
|
2020
Q4 | $325K | Buy |
+43,640
| New | +$325K | ﹤0.01% | 2433 |
|
|
2020
Q2 | – | Sell |
-36,720
| Closed | -$73K | – | 2622 |
|
|
2020
Q1 | $73K | Sell |
36,720
-1,722,120
| -98% | -$3.42M | ﹤0.01% | 2571 |
|
|
2019
Q4 | $6.07M | Buy |
1,758,840
+101,461
| +6% | +$350K | 0.01% | 1087 |
|
|
2019
Q3 | $4.75M | Buy |
1,657,379
+166,025
| +11% | +$476K | 0.01% | 1162 |
|
|
2019
Q2 | $5.65M | Buy |
1,491,354
+152,659
| +11% | +$579K | 0.01% | 1116 |
|
|
2019
Q1 | $10.9M | Sell |
1,338,695
-160,787
| -11% | -$1.31M | 0.01% | 801 |
|
|
2018
Q4 | $12.1M | Sell |
1,499,482
-208,837
| -12% | -$1.69M | 0.02% | 718 |
|
|
2018
Q3 | $13M | Buy |
1,708,319
+74,447
| +5% | +$568K | 0.02% | 717 |
|
|
2018
Q2 | $9.36M | Buy |
1,633,872
+669,566
| +69% | +$3.84M | 0.01% | 831 |
|
|
2018
Q1 | $4.6M | Buy |
964,306
+24,833
| +3% | +$118K | 0.01% | 1106 |
|
|
2017
Q4 | $4.61M | Sell |
939,473
-552,844
| -37% | -$2.71M | 0.01% | 1097 |
|
|
2017
Q3 | $7.82M | Sell |
1,492,317
-595,690
| -29% | -$3.12M | 0.01% | 815 |
|
|
2017
Q2 | $11.6M | Sell |
2,088,007
-1,065,621
| -34% | -$5.92M | 0.02% | 641 |
|
|
2017
Q1 | $26.5M | Sell |
3,153,628
-529,523
| -14% | -$4.45M | 0.05% | 375 |
|
|
2016
Q4 | $23.3M | Buy |
3,683,151
+18,284
| +0.5% | +$116K | 0.04% | 411 |
|
|
2016
Q3 | $16.2M | Buy |
3,664,867
+231,215
| +7% | +$1.02M | 0.03% | 484 |
|
|
2016
Q2 | $9.75M | Sell |
3,433,652
-621,414
| -15% | -$1.76M | 0.02% | 696 |
|
|
2016
Q1 | $11.5M | Buy |
4,055,066
+1,487,851
| +58% | +$4.21M | 0.02% | 606 |
|
|
2015
Q4 | $26.5M | Buy |
2,567,215
+94,241
| +4% | +$973K | 0.04% | 362 |
|
|
2015
Q3 | $28.2M | Buy |
2,472,974
+304,722
| +14% | +$3.47M | 0.04% | 358 |
|
|
2015
Q2 | $32.4M | Buy |
2,168,252
+444,115
| +26% | +$6.63M | 0.05% | 341 |
|
|
2015
Q1 | $15.6M | Buy |
1,724,137
+53,598
| +3% | +$484K | 0.02% | 516 |
|
|
2014
Q4 | $20.3M | Sell |
1,670,539
-421,822
| -20% | -$5.13M | 0.03% | 444 |
|
|
2014
Q3 | $20.5M | Sell |
2,092,361
-329,857
| -14% | -$3.23M | 0.03% | 416 |
|
|
2014
Q2 | $30.9M | Buy |
2,422,218
+353,158
| +17% | +$4.5M | 0.04% | 304 |
|
|
2014
Q1 | $21.9M | Sell |
2,069,060
-371,117
| -15% | -$3.93M | 0.03% | 396 |
|
|
2013
Q4 | $18.5M | Buy |
2,440,177
+1,617,669
| +197% | +$12.3M | 0.03% | 427 |
|
|
2013
Q3 | $5.99M | Buy |
822,508
+748,058
| +1,005% | +$5.45M | 0.01% | 767 |
|
|
2013
Q2 | $115K | Buy |
+74,450
| New | +$115K | ﹤0.01% | 2256 |
|